Trial intelligence / Profile preview

Effect of atropine + neostigmine injection speed on heart rate during reversal of neuromuscular blockade

IRCT20230405057822N1Phase 3Completed

Sponsor
Shahid Sadoughi University of Medical Sciences
Start
Oct 2021
Modality
Classical Binding Small Molecules → Small Molecules, Small Molecules
Countries
1
01

Overview

Phase 3, randomised, double-blind trial of atropine and neostigmine (3 arms), sponsored by Shahid Sadoughi University of Medical Sciences. Primary endpoint: Pulse rate. Started Oct 2021; status: completed.

02

Drugs

atropineneostigmine

Beyond the preview

Go deeper on IRCT20230405057822N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20230405057822N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call